Journal: Annals of surgical oncology
The publication evaluates the efficacy and safety of a novel therapeutic approach in cancer treatment, focusing on patient outcomes and tumor response rates.
The study presents a comprehensive analysis of clinical data, highlighting:
- Improvements in progression-free survival
- Manageable toxicity profiles
The findings support the potential integration of this treatment into current oncologic practice, pending further validation in larger cohorts.